Skip to main content
Top
Published in: Diabetology International 1/2010

01-11-2010 | Original article

Leptin mediates the relationship between abdominal obesity and microalbuminuria in type 2 diabetic patients

Authors: Ko Hanai, Tetsuya Babazono, Naoshi Yoshida, Izumi Nyumura, Kiwako Toya, Toshihide Hayashi, Ryotaro Bouchi, Nobue Tanaka, Akiko Ishii, Yasuhiko Iwamoto

Published in: Diabetology International | Issue 1/2010

Login to get access

Abstract

Background

Abdominal obesity has been implicated in the pathogenesis of microalbuminuria in patients with diabetes; however, the underlying mechanisms remain unclear. Increased leptin secretion by adipocytes may be one of the factors responsible for the relationship between abdominal obesity and microalbuminuria, because increased leptin secretion has been demonstrated to contribute to renal impairment. We therefore conducted a cross-sectional study to clarify the relationship between increased serum leptin levels associated with abdominal obesity and albuminuria in patients with type 2 diabetes mellitus (T2DM).

Methods

We studied a total of 502 adult patients with T2DM, 220 women and 282 men, with a mean (±SD) age of 60 ± 13 years. Patients with macroalbuminuria and those with an estimated glomerular filtration rate of <15 ml/min/1.73 m2 were excluded. Waist circumference was used as a surrogate marker of abdominal obesity. For statistical analyses, analysis of covariance and multivariate linear regression analysis were conducted.

Results

The geometric mean (95% confidence interval) of serum leptin levels adjusted for conventional risk factors was significantly higher in patients with microalbuminuria than in those with normoalbuminuria [5.6 (5.3–5.9) vs. 6.3 (5.8–6.8) ng/ml, p = 0.030]. In the multiple regression analysis, waist circumference was significantly associated with urinary albumin excretion, though statistical significance disappeared when serum leptin levels were incorporated into this model. Serum leptin levels remained significantly associated with urinary albumin excretion.

Conclusions

Leptin may be a factor mediating the relationship between abdominal obesity and microalbuminuria in patients with T2DM.
Literature
1.
go back to reference Dinneen SF, Gerstein HC. The association of microalbuminuria and mortality in non-insulin-dependent diabetes mellitus. A systemic overview of the literature. Arch Intern Med. 1997;157:1413–8.CrossRefPubMed Dinneen SF, Gerstein HC. The association of microalbuminuria and mortality in non-insulin-dependent diabetes mellitus. A systemic overview of the literature. Arch Intern Med. 1997;157:1413–8.CrossRefPubMed
2.
go back to reference Retnakaran R, Cull CA, Thorne KI, Adler AI, Holman RR, for the UKPDS Study Group. Risk factors for renal dysfunction in type 2 diabetes. Diabetes. 2006;55:1832–9.CrossRefPubMed Retnakaran R, Cull CA, Thorne KI, Adler AI, Holman RR, for the UKPDS Study Group. Risk factors for renal dysfunction in type 2 diabetes. Diabetes. 2006;55:1832–9.CrossRefPubMed
3.
go back to reference The Diabetes Control and Complications Trial Research Group. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med. 1993;329:977–86.CrossRef The Diabetes Control and Complications Trial Research Group. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med. 1993;329:977–86.CrossRef
4.
go back to reference Hanai K, Babazono T, Iwamoto Y. Renal manifestations of metabolic syndrome in type 2 diabetes. Diabetes Res Clin Pract. 2008;79:318–24.CrossRefPubMed Hanai K, Babazono T, Iwamoto Y. Renal manifestations of metabolic syndrome in type 2 diabetes. Diabetes Res Clin Pract. 2008;79:318–24.CrossRefPubMed
5.
go back to reference Singh P, Hoffmann M, Wolk R, Shamsuzzaman AS, Somers VK. Leptin induces C-reactive protein expression in vascular endothelial cells. Arterioscler Thromb Vasc Biol. 2007;27:e302–7.CrossRefPubMed Singh P, Hoffmann M, Wolk R, Shamsuzzaman AS, Somers VK. Leptin induces C-reactive protein expression in vascular endothelial cells. Arterioscler Thromb Vasc Biol. 2007;27:e302–7.CrossRefPubMed
6.
go back to reference Franks PW, Brage S, Luan J, et al. Leptin predicts a worsening of the features of the metabolic syndrome independently of obesity. Obes Res. 2005;13:1476–84.CrossRefPubMed Franks PW, Brage S, Luan J, et al. Leptin predicts a worsening of the features of the metabolic syndrome independently of obesity. Obes Res. 2005;13:1476–84.CrossRefPubMed
7.
go back to reference Wolf G, Hamann A, Han DC, et al. Leptin stimulates proliferation and TGF-beta expression in renal glomerular endothelial cells: potential role in glomerulosclerosis. Kidney Int. 1999;56:860–72.CrossRefPubMed Wolf G, Hamann A, Han DC, et al. Leptin stimulates proliferation and TGF-beta expression in renal glomerular endothelial cells: potential role in glomerulosclerosis. Kidney Int. 1999;56:860–72.CrossRefPubMed
8.
go back to reference Alvarez GE, Beske SD, Ballard TP, Davy KP. Sympathetic neural activation in visceral obesity. Circulation. 2002;106:2533–6.CrossRefPubMed Alvarez GE, Beske SD, Ballard TP, Davy KP. Sympathetic neural activation in visceral obesity. Circulation. 2002;106:2533–6.CrossRefPubMed
9.
go back to reference Wiecek A, Kokot F, Chudek J, Adamczak M. The adipose tissue—a novel endocrine organ of interest to the nephrologists. Nephrol Dial Transplant. 2002;17:191–5.CrossRefPubMed Wiecek A, Kokot F, Chudek J, Adamczak M. The adipose tissue—a novel endocrine organ of interest to the nephrologists. Nephrol Dial Transplant. 2002;17:191–5.CrossRefPubMed
10.
go back to reference Chen K, Li F, Li J, et al. Induction of leptin resistance through direct interaction of C-reactive protein with leptin. Nat Med. 2006;12:425–32.CrossRefPubMed Chen K, Li F, Li J, et al. Induction of leptin resistance through direct interaction of C-reactive protein with leptin. Nat Med. 2006;12:425–32.CrossRefPubMed
11.
go back to reference Jager A, van Hinsbergh VWM, Kostense PJ, et al. C-reactive protein and soluble vascular cell adhesion molecule-1 are associated with elevated urinary albumin excretion but do not explain its link with cardiovascular risk. Arterioscler Thromb Vasc Biol. 2002;22:593–8.CrossRefPubMed Jager A, van Hinsbergh VWM, Kostense PJ, et al. C-reactive protein and soluble vascular cell adhesion molecule-1 are associated with elevated urinary albumin excretion but do not explain its link with cardiovascular risk. Arterioscler Thromb Vasc Biol. 2002;22:593–8.CrossRefPubMed
12.
go back to reference Merabet E, Dagogo-Jack S, Coyne DW, et al. Increased plasma leptin concentration in end-stage renal disease. J Clin Endocrinol Metab. 1997;82:847–50.CrossRefPubMed Merabet E, Dagogo-Jack S, Coyne DW, et al. Increased plasma leptin concentration in end-stage renal disease. J Clin Endocrinol Metab. 1997;82:847–50.CrossRefPubMed
13.
go back to reference Wilson C, Nelson R, Nicolson M, Pratley R. Plasma leptin concentrations: no difference between diabetic Pima Indians with and without nephropathy. Diabetologia. 1998;41:861–2.CrossRefPubMed Wilson C, Nelson R, Nicolson M, Pratley R. Plasma leptin concentrations: no difference between diabetic Pima Indians with and without nephropathy. Diabetologia. 1998;41:861–2.CrossRefPubMed
14.
go back to reference Fruehwald-Schultes B, Kern W, Beyer J, Forst T, Pfuetzner A, Peters A. Elevated serum leptin concentrations in type 2 diabetic patients with microalbuminuria and macroalbuminuria. Metabolism. 1999;48:1290–3.CrossRefPubMed Fruehwald-Schultes B, Kern W, Beyer J, Forst T, Pfuetzner A, Peters A. Elevated serum leptin concentrations in type 2 diabetic patients with microalbuminuria and macroalbuminuria. Metabolism. 1999;48:1290–3.CrossRefPubMed
15.
go back to reference Chan WB, Ma RC, Chan NN, et al. Increased leptin concentrations and lack of gender difference in type 2 diabetic patients with nephropathy. Diabetes Res Clin Pract. 2004;64:93–8.CrossRefPubMed Chan WB, Ma RC, Chan NN, et al. Increased leptin concentrations and lack of gender difference in type 2 diabetic patients with nephropathy. Diabetes Res Clin Pract. 2004;64:93–8.CrossRefPubMed
16.
go back to reference Matsuda M, Kawasaki F, Yamada K, et al. Impact of adiposity and plasma adipocytokines on diabetic angiopathies in Japanese type 2 diabetic subjects. Diabet Med. 2004;21:881–8.CrossRefPubMed Matsuda M, Kawasaki F, Yamada K, et al. Impact of adiposity and plasma adipocytokines on diabetic angiopathies in Japanese type 2 diabetic subjects. Diabet Med. 2004;21:881–8.CrossRefPubMed
17.
go back to reference Barlovic DP, Zaletel J, Prezelj J. Adipocytokines are associated with renal function in patients with normal range glomerular filtration rate and type 2 diabetes. Cytokine. 2009;46:142–5.CrossRefPubMed Barlovic DP, Zaletel J, Prezelj J. Adipocytokines are associated with renal function in patients with normal range glomerular filtration rate and type 2 diabetes. Cytokine. 2009;46:142–5.CrossRefPubMed
18.
go back to reference The committee of the Japan Diabetes Society on the diagnostic criteria of diabetes mellitus, Kuzuya T, Nakagawa S, et al. Report of the committee on the classification and diagnostic criteria of diabetes mellitus. Diabetes Res Clin Pract. 2002;55:65–85.CrossRefPubMed The committee of the Japan Diabetes Society on the diagnostic criteria of diabetes mellitus, Kuzuya T, Nakagawa S, et al. Report of the committee on the classification and diagnostic criteria of diabetes mellitus. Diabetes Res Clin Pract. 2002;55:65–85.CrossRefPubMed
19.
go back to reference Levey AS, Eckardt KU, Tsukamoto Y, et al. Definition and classification of chronic kidney disease: a position statement from kidney disease: improving global outcomes (KDIGO). Kidney Int. 2005;67:2089–100.CrossRefPubMed Levey AS, Eckardt KU, Tsukamoto Y, et al. Definition and classification of chronic kidney disease: a position statement from kidney disease: improving global outcomes (KDIGO). Kidney Int. 2005;67:2089–100.CrossRefPubMed
20.
go back to reference Warram JH, Gearin G, Laffel L, Krolewski AS. Effect of duration of type 1 diabetes on the prevalence of stages of diabetic nephropathy defined by urinary albumin/creatinine ratio. J Am Soc Nephrol. 1996;7:930–7.PubMed Warram JH, Gearin G, Laffel L, Krolewski AS. Effect of duration of type 1 diabetes on the prevalence of stages of diabetic nephropathy defined by urinary albumin/creatinine ratio. J Am Soc Nephrol. 1996;7:930–7.PubMed
21.
go back to reference Mattix HJ, Hsu CY, Shaykevich S, Curhan G. Use of the albumin/creatinine ratio to detect microalbuminuria: implications of sex and race. J Am Soc Nephrol. 2002;13:1034–9.PubMed Mattix HJ, Hsu CY, Shaykevich S, Curhan G. Use of the albumin/creatinine ratio to detect microalbuminuria: implications of sex and race. J Am Soc Nephrol. 2002;13:1034–9.PubMed
22.
go back to reference Matsuo S, Imai E, Horio M, et al. Revised equations for estimated GFR from serum creatinine in Japan. Am J Kidney Dis. 2009;53:982–92.CrossRefPubMed Matsuo S, Imai E, Horio M, et al. Revised equations for estimated GFR from serum creatinine in Japan. Am J Kidney Dis. 2009;53:982–92.CrossRefPubMed
23.
go back to reference Matsuzawa Y. Metabolic syndrome: definition and diagnostic criteria in Japan. J Jpn Soc Intern Med. 2005;94:188–203. Matsuzawa Y. Metabolic syndrome: definition and diagnostic criteria in Japan. J Jpn Soc Intern Med. 2005;94:188–203.
24.
go back to reference Perkins NJ, Schisterman EF. The inconsistency of ‘‘optimal’’ cutpoints obtained using two criteria based on the receiver operating characteristic curve. Am J Epidemiol. 2006;163:670–5.CrossRefPubMed Perkins NJ, Schisterman EF. The inconsistency of ‘‘optimal’’ cutpoints obtained using two criteria based on the receiver operating characteristic curve. Am J Epidemiol. 2006;163:670–5.CrossRefPubMed
25.
26.
go back to reference Schlaich MP, Socratous F, Hennebry S, et al. Sympathetic activation in chronic renal failure. J Am Soc Nephrol. 2009;20:933–9.CrossRefPubMed Schlaich MP, Socratous F, Hennebry S, et al. Sympathetic activation in chronic renal failure. J Am Soc Nephrol. 2009;20:933–9.CrossRefPubMed
27.
28.
go back to reference Calabro P, Willerson JT, Yeh ET. Inflammatory cytokines stimulated C-reactive protein production by human coronary artery smooth muscle cells. Circulation. 2003;108:1930–2.CrossRefPubMed Calabro P, Willerson JT, Yeh ET. Inflammatory cytokines stimulated C-reactive protein production by human coronary artery smooth muscle cells. Circulation. 2003;108:1930–2.CrossRefPubMed
29.
go back to reference Vestra MD, Mussap M, Gallina P, et al. Acute-phase markers of inflammation and glomerular structure in patients with type 2 diabetes. J Am Soc Nephrol. 2005;16:S78–82.CrossRefPubMed Vestra MD, Mussap M, Gallina P, et al. Acute-phase markers of inflammation and glomerular structure in patients with type 2 diabetes. J Am Soc Nephrol. 2005;16:S78–82.CrossRefPubMed
30.
go back to reference Abdullah SM, Khera A, Leonard D, et al. Sex differences in the association between leptin and CRP: Results from the Dallas Heart Study. Atherosclerosis. 2007;195:404–10.CrossRefPubMed Abdullah SM, Khera A, Leonard D, et al. Sex differences in the association between leptin and CRP: Results from the Dallas Heart Study. Atherosclerosis. 2007;195:404–10.CrossRefPubMed
31.
go back to reference Hanai K, Babazono T, Nyumura I, et al. Involvement of visceral fat in the pathogenesis of albuminuria in patients with type 2 diabetes with early stage of nephropathy. Clin Exp Nephrol. 2010;14:132–6.CrossRefPubMed Hanai K, Babazono T, Nyumura I, et al. Involvement of visceral fat in the pathogenesis of albuminuria in patients with type 2 diabetes with early stage of nephropathy. Clin Exp Nephrol. 2010;14:132–6.CrossRefPubMed
32.
go back to reference The Examination Committee of Criteria for ‘Obesity Disease’ in Japan, Japan Society for the Study of Obesity. New criteria for ‘obesity disease’ in Japan. Circ J. 2002;66:987–92. The Examination Committee of Criteria for ‘Obesity Disease’ in Japan, Japan Society for the Study of Obesity. New criteria for ‘obesity disease’ in Japan. Circ J. 2002;66:987–92.
33.
go back to reference Hara K, Matsushita Y, Horikoshi M, et al. A proposal for the cutoff point of waist circumference for the diagnosis of metabolic syndrome in the Japanese population. Diabetes Care. 2006;29:1123–4.CrossRefPubMed Hara K, Matsushita Y, Horikoshi M, et al. A proposal for the cutoff point of waist circumference for the diagnosis of metabolic syndrome in the Japanese population. Diabetes Care. 2006;29:1123–4.CrossRefPubMed
34.
go back to reference Matoba Y, Inoguchi T, Nasu S, et al. Optimal cut points of waist circumference for the clinical diagnosis of metabolic syndrome in the Japanese population. Diabetes Care. 2008;31:590–2.CrossRefPubMed Matoba Y, Inoguchi T, Nasu S, et al. Optimal cut points of waist circumference for the clinical diagnosis of metabolic syndrome in the Japanese population. Diabetes Care. 2008;31:590–2.CrossRefPubMed
35.
go back to reference Gansevoort RT, Verhave JC, Hillege HL, et al. The validity of screening based on spot morning urine samples to detect subjects with microalbuminuria in the general population. Kidney Int. 2005;94(Suppl):S28–35.CrossRef Gansevoort RT, Verhave JC, Hillege HL, et al. The validity of screening based on spot morning urine samples to detect subjects with microalbuminuria in the general population. Kidney Int. 2005;94(Suppl):S28–35.CrossRef
36.
go back to reference Babazono T, Takahashi C, Iwamoto Y. Definition of microalbuminuria in first-morning and random spot urine in diabetic patients. Diabetes Care. 2004;27:1838–9.CrossRefPubMed Babazono T, Takahashi C, Iwamoto Y. Definition of microalbuminuria in first-morning and random spot urine in diabetic patients. Diabetes Care. 2004;27:1838–9.CrossRefPubMed
Metadata
Title
Leptin mediates the relationship between abdominal obesity and microalbuminuria in type 2 diabetic patients
Authors
Ko Hanai
Tetsuya Babazono
Naoshi Yoshida
Izumi Nyumura
Kiwako Toya
Toshihide Hayashi
Ryotaro Bouchi
Nobue Tanaka
Akiko Ishii
Yasuhiko Iwamoto
Publication date
01-11-2010
Publisher
Springer Japan
Published in
Diabetology International / Issue 1/2010
Print ISSN: 2190-1678
Electronic ISSN: 2190-1686
DOI
https://doi.org/10.1007/s13340-010-0004-9

Other articles of this Issue 1/2010

Diabetology International 1/2010 Go to the issue